Allison advises companies of all stages and sizes, from formation and early fund raising through private financings of all stages, mergers and acquisitions, IPOs and other public offerings as well as, corporate governance and SEC reporting.
Renasant Bio Launches With $54.5 Million Seed Financing
July 10, 2025
Cooley advised Renasant Bio, a preclinical venture-backed biotech company focused on developing therapies for rare genetic kidney diseases, on its launch with $54.5 million in seed funding.
Personalis Announces Expanded Collaboration With Tempus AI
August 16, 2024
Cooley advised Personalis, a company transforming the active management of cancer through breakthrough personalized testing, on its expanded commercial relationship with Tempus AI, including an equity investment by Tempus into Personalis.
Dutch Bros Announces $344 Million Secondary Public Offering
June 12, 2024
Cooley advised Dutch Bros (NYSE: BROS), a publicly held drive-thru coffee chain, on its $344 million secondary public offering of Class A common stock.
Cooley advised Lacework, a data-driven cloud security company, on its definitive agreement to be acquired by Fortinet (Nasdaq: FTNT), the global cybersecurity leader driving the convergence of networking and security.
